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INTRODUCTION
NADPH oxidases are a major source of superoxide and downstream reactive oxygen species (ROS) in the vasculature and upregulation of these enzymes is a major cause of the oxidative stress associated with vascular diseases (Bengtsson et al., 2003; Madamanchi et al., 2005) . NADPH oxidases generate superoxide by transferring electrons from the pyridine nucleotide, NADPH [and possibly NADH; see (Lassegue and Clempus, 2003) ] to molecular oxygen. These enzymes were first identified in neutrophils as the enzyme complex responsible for the respiratory burst; however, recently isoforms of NADPH oxidase have been identified in nonphagocytic cells, including all major cell types that make up the blood vessel wall (i.e. endothelial and smooth muscle cells and adventitial fibroblasts) (Lassegue and Clempus, 2003) .
At least three isoforms of NADPH oxidase have been identified in the vascular wall, all of which are built on the same basic molecular plan consisting of cytosolic organiser (p47phox or NoxO1) and activator (p67phox or NoxA1) subunits, a small G-protein, (Rac1 or Rac2) and a membranebound cytochrome b558 reductase domain (Lassegue and Clempus, 2003) . Cytochrome b558 is actually a heterodimer made up of a small α-subunit, p22phox, and a larger catalytic β-subunit or Nox, the nature of which varies with different isoforms of the enzyme (Lassegue and Clempus, 2003) . Within vascular cells NADPH oxidase isoforms containing Nox1, Nox2 (gp91phox) and Nox4 have been identified (Bengtsson et al., 2003; Lassegue and Clempus, 2003) .
In contrast to the NADPH oxidase expressed in phagocytes, which only becomes activated following exposure of cells to pathogens or pro-inflammatory mediators, a large pool of vascular NADPH oxidase is constitutively assembled (Li and Shah, 2002) . This characteristic of the vascular enzyme means that addition of an excess of the pyridine nucleotide substrate, NADPH (or NADH) alone to vascular preparations is sufficient to increase superoxide This article has not been copyedited and formatted. The final version may differ from this version.
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JPET # 96610 5 production (Li and Shah, 2002) . Interestingly, NADPH appears to be equally effective at driving superoxide production whether added to intact or permeabilised preparations (Pagano et al., 1995; Li and Shah, 2001; Souza et al., 2001; Ellmark et al., 2005) indicating either that extracellular NAD(P)H gains entry to the intracellular compartment by an undefined mechanism or that the NAD(P)H binding site of vascular NADPH oxidase is accessible from the extracellular surface of the plasma membrane.
ROS are known to elicit a range of effects on vascular tone ranging from H 2 O 2 -mediated opening of K + channels and subsequent vasodilatation, to vasoconstriction arising from superoxide-dependent inactivation of nitric oxide (NO). Hence, a number of recent studies have examined the vasomotor effects of NADPH and NADH in vitro and in vivo in order to assess the role of NADPH oxidase in regulation of vascular tone (Souza et al., 2001; Didion and Faraci, 2002; Paravicini et al., 2004; Park et al., 2004) . However, in addition to augmenting NADPH oxidase activity, pyridine nucleotides could conceivably modulate vascular tone via stimulation of P2 nucleotide receptors. Indeed, many blood vessels are known to express nucleotide receptors both on the endothelial and smooth muscle layers (Kunapuli and Daniel, 1998) .
Moreover, in non-vascular smooth muscle preparations including the guinea pig taenia coli and rat anococcygeus muscle, responses to NADPH and NADH were due to activation of P2 and A1
receptors, respectively (Burnstock and Hoyle, 1985; Najbar et al., 1994) . Of note, there were no qualitative differences between the oxidised [NAD(P) + ; electron depleted] and reduced forms of each nucleotide in terms of their ability to modulate smooth muscle tone (Najbar et al., 1994) , providing further evidence for a non-NADPH oxidase-dependent action.
In the present study, we examined the relative contributions of NADPH-dependent oxidases (e.g. NADPH oxidase and nitric oxide synthase) and P2 nucleotide receptors to vascular responses (superoxide production and vasocontraction) elicited by NADPH in mouse isolated This article has not been copyedited and formatted. The final version may differ from this version. JPET # 96610 6 thoracic aortas for the following two reasons: (1) the mouse aorta is known to express a functional NADPH oxidase and addition of NADPH to intact rings has previously been shown increase both superoxide production and vascular tone (Souza et al., 2001) ; and (2) P2 receptors were recently established to be expressed on both the endothelium and vascular smooth muscle cell layers of the mouse aorta and these receptors could conceivably contribute to the established vasoconstrictor effects of NADPH in this tissue (Beny, 2004) . Our findings confirm previous observations that NADPH increases superoxide production from NADPH oxidase in the mouse aorta. However, this action does not contribute to the vasoconstrictor effects of NADPH in this tissue. Rather, activation of P2X receptors on both the endothelium and smooth muscle layers is the predominant mechanism by which NADPH modulates aortic tone.
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Lucigenin-enhanced chemiluminescence
Following isolation, the thoracic aorta was immediately placed in ice-cold Krebs-HEPES buffer containing (in mM) NaCl 99, KCl 4.7, KH 2 PO 4 1.0, MgSO 4 1.2, CaCl 2 2.5, NaHCO 3 25, Na-HEPES 20 & glucose 11 (pH 7.4). Aortas were cleared of adherent fat and cut into 2mm rings.
In some rings the endothelium was removed by gently abrading the luminal surface of the vessel with a stainless steel pin. Vascular superoxide production was measured by 5µM lucigeninenhanced chemiluminescence as described previously (Paravicini et al., 2002 Krebs-bicarbonate buffer and gradually warmed to 37°C before being mounted on two stainless steel wire callipers (100µm diameter), one connected to a force displacement transducer and the other to a micrometer. Rings were then incubated under zero tension for 20 mins, after which time the baseline tension was elevated to 5mN by manually adjusting the micrometer. After a further 30 mins, maximal contractions of the tissue (U max ) was determined using U46619 (0.3µM, 15 mins). Aortic rings were then washed with fresh Krebs (x3) and allowed to return to baseline tension (~40 mins). Some rings were then treated for 20 minutes with one of the following inhibitor drugs: tiron (10mM); diphenyleneiodonium (5µM); L-NAME ( to confirm the presence / absence of a functional endothelium.
Drugs
Acetylcholine chloride (Ach), allopurinol, α ,β-Methylene-adenosine 5′-triphosphate lithium salt (α,β-methylene-ATP), β -nicotinamide adenine dinucleotide phosphate oxidised sodium salt (NADP + ), β-nicotinamide adenine dinucleotide phosphate reduced tetrasodium salt (NADPH), β -nicotinamide adenine dinucleotide reduced disodium salt hydrate (NADH), Cu 2+ /Zn 2+ -superoxide dismutase from bovine erythrocytes (SOD1), 9,11-Dideoxy-11α,9α-epoxymethanoprostaglandin 
RESULTS
Vasocontractions to NADPH are endothelium-and superoxide-dependent
Lucigenin-enhanced chemiluminescence was barely detectable in mouse isolated aortic rings under basal conditions ( Figure 1A ). However, exposure to exogenous NADPH caused a concentration-dependent increase in chemiluminescence (pEC 50 , 3.7 ± 0.3; R max , 11443 ± 1521 RLU/s/mg), which was further enhanced in the presence of the SOD inactivating agent, DETCA (pEC 50 , 4.0 ± 0.1; R max , 51081 ± 5454 RLU/s/mg; P<0.01; Figure 1A ). NADPH-dependent chemiluminescence was markedly inhibited by the cell permeable superoxide scavenging compound, tiron, confirming that the assay was specific for superoxide, whereas cell impermeable SOD2 had no effect ( Figure 1B ). Likewise, a structurally unrelated superoxide scavenger, M40403, inhibited chemiluminescence, while SOD1 had no effect (see Online Data Supplement - Figure 1) . Also, NADPH-dependent superoxide production was augmented by ~50% by mechanical removal of the endothelium ( Figure 1C ).
In isometric tension studies, NADPH caused concentration-dependent contractions in rings of aorta precontracted with U46619 (Figures 2A and B) . NADPH elicited a similar effect on vascular tone in rings of artery precontracted with phenylephrine but had no effect in rings maintained under resting tension (see Online Data Supplement - Figure 2) . Removal of the endothelium inhibited contractions to NADPH by ~50% ( Figure 2B ) and relaxations to Ach by ~80% ( Figure 2C ). Interestingly, tiron had no significant effect on contractions to NADPH in endothelium-intact tissues but markedly attenuated the response in endothelium-denuded tissues ( Figure 2A ). Tiron had no effect on responses to Ach in endothelium-intact or -denuded tissues ( Figure 2B ).
This article has not been copyedited and formatted. The final version may differ from this version. Vasocontractions to NADPH occur independently of NADPH oxidase and eNOS activity.
Whereas reduced NADPH stimulated a large increase in superoxide production, its oxidation product, NADP + , which lacks a donatable hydride ion (electron) and thus the ability to support enzymatic reduction of molecular oxygen, failed to induce superoxide production above basal levels ( Figure 3A) . NADH, which has been mooted as an alternative/preferred substrate for some isoforms of NADPH oxidase (Lassegue and Clempus, 2003) , also had no significant effect on superoxide levels ( Figure 3A) . Surprisingly, despite its inability to stimulate superoxide production, NADP + was equally as effective as NADPH at eliciting contractions in precontracted mouse aortic rings ( Figure 3B ). In contrast, NADH induced a small relaxation response ( Figure   3B ).
The above findings indicate that the effect of NADPH on aortic tone may not always be related to its ability to augment superoxide production from NADPH-dependent vascular oxidases such as NADPH oxidase. To further explore this possibility we compared the effects of known inhibitors of NADPH oxidase and other potential sources of vascular ROS, on superoxide production and contraction. NADPH-dependent superoxide production was significantly reduced after acute exposure of aortic rings to the flavin antagonist and non-selective NADPH oxidase inhibitor, diphenyleneiodonium (P<0.001, n=6; Figure 4A ). Consistent with our previous observation in mouse cultured vascular smooth muscle cells (Ellmark et al., 2005) , short term incubation with apocynin failed to reduce NADPH-dependent superoxide production ( Figure   4A ). In contrast, when the exposure time to apocynin was increased to 24h, NADPH-stimulated superoxide production appeared to be markedly attenuated ( Figure 4B) ; however, this effect just failed to reach statistical significance due to the large variation in control responses to NADPH in aortic rings after 24h of organoid culture. L-NAME, an inhibitor of nitric oxide synthase, also appeared to reduce NADPH-dependent superoxide production by ~40%, but again this just failed This article has not been copyedited and formatted. The final version may differ from this version. 13 to reach significance, while inhibitors of cyclooxygenase (indomethacin), xanthine oxidase (allopurinol), and the mitochondrial electron transport chain (rotenone), had no effect ( Figure   4C ). These results suggest that NADPH oxidase (and possibly eNOS) contribute to vascular superoxide production in response to NADPH. However, neither diphenyleneiodonium nor L-NAME had any effect on the contractile response to NADPH in isolated aortic rings ( Figure 5A) despite both treatments abolishing endothelium-dependent relaxations to Ach ( Figure 5B ).
Vasocontractions to NADPH are mediated by P2X receptors.
NADPH has previously been described as an agonist of P 2 receptors (Burnstock and Hoyle, 1985; Najbar et al., 1994) . Therefore, we examined the influence of α ,β-methylene-ATP (a P2X desensitising agent) on NADPH-induced vasocontractions in mouse isolated aorta. α ,β-methylene-ATP caused large contractions, which were similar in magnitude in endotheliumintact and -denuded rings of aorta. In both cases, responses to α ,β-methylene-ATP spontaneously returned to baseline levels of tension after 3 minutes, presumably reflecting desensitisation of the P2X effector pathways that lead to vasocontraction in this tissue. Pretreatment with α ,β-methylene-ATP had no effect on the concentration of U46619 required to precontract tissues to ~50% U max but markedly attenuated responses to NADPH in both endothelium-intact and denuded tissues ( Figure 6A ). In contrast, α ,β-methylene-ATP had no effect on NADPH-induced superoxide production in mouse aortic rings ( Figure 6B ), further highlighting the fact that NADPH induces vasocontraction and superoxide production via different mechanisms.
To confirm the involvement of P2X receptors in vasocontractions to NADPH, we examined the effects of PPADS, a broad selectivity P2X receptor antagonist, and NF023, which is a relatively selective P2X1 antagonist. Vasocontractions to NADPH in both endotheliumdenuded and -intact tissues were virtually abolished in the presence of PPADS ( Figure 7A ).
DISCUSSION
Recently a number of studies have examined the effect of NADPH (and NADH) on vascular tone with a view to determining the role of NADPH oxidase in this response (Souza et al., 2001; Didion and Faraci, 2002; Paravicini et al., 2004; Park et al., 2004) . However, here we have shown that contractile responses to NADPH in the mouse isolated aorta are not dependent on NADPH oxidase activity. Thus, although exogenous NADPH was highly effective at augmenting NADPH oxidase activity, its contractile effects were insensitive to diphenyleneiodonium and L-NAME, excluding any role for NADPH oxidase and superoxidedependent inactivation of NO in the vasomotor response. Rather, vasocontractions to NADPH were mediated by activation of two distinct populations of P2X receptors, one located on the endothelium and the other on the smooth muscle layer.
In this study, as in previous studies by our group (Paravicini et al., 2002; Paravicini et al., 2004 ) and others (Pagano et al., 1995) , exogenous NADPH stimulated superoxide production in intact vascular ring segments. Superoxide production was virtually abolished by diphenyleneiodonium and was markedly attenuated by apocynin suggesting that NADPH oxidase is primarily responsible for superoxide production in response to NADPH in mouse isolated aortic segments. These findings obtained using the lucigenin technique are thus consistent with those of Souza et al., who, using electron paramagnetic spin resonance, similarly showed that extracellular NADPH stimulates superoxide production in intact aortic segments (Souza et al., 2001 ). Furthermore, these authors showed that superoxide production in response to NADPH was similar in aortas from wild-type and Nox2-knockout mice, implicating a non-phagocytic isoform of NADPH oxidase in the response (Souza et al., 2001) . While it remains to be determined which isoform(s) is involved in supporting NADPH-dependent superoxide production This article has not been copyedited and formatted. The final version may differ from this version. in whole ring segments, we have recently demonstrated a major role for a Nox4-containing NADPH oxidase in NADPH-dependent superoxide production in mouse cultured aortic smooth muscle cells (Ellmark et al., 2005) . This is further supported by our observation that Nox4 is by far the most abundantly expressed NADPH oxidase isoform in the mouse aorta (Bengtsson et al., 2003) .
In addition to elevating superoxide production, exogenous NADPH also caused concentration-dependent contractions in mouse aortic rings, which were partially dependent on the presence of a functional endothelium. However, our data indicates that NADPH did not mediate contraction via its ability to act as a reducing equivalent for NADPH oxidase-dependent superoxide generation and subsequent inactivation of NO. First, removal of the endothelium inhibited contractions to NADPH yet augmented superoxide production, this latter effect suggesting that endothelial cells exert a tonic suppressive effect on NADPH oxidase activity.
Second, NADP + , which lacks a donatable hydride ion, was equally as effective as NADPH at causing contraction. Third, diphenyleneiodonium, which abolished NADPH oxidase-dependent superoxide production in mouse aortic rings, had no effect on NADPH-induced contractions.
Finally, contractions to NADPH were not affected by the NOS inhibitor, L-NAME, indicating that they were independent of NO. Rather, both the endothelium-dependent and -independent components of the contractile response to NADPH were virtually abolished by the P2X receptor desensitising agent α,β-methylene-ATP and were markedly inhibited by the P2X antagonists, PPADS & NF023, implicating a role for P2X receptors in the response.
Although NADPH has previously been shown to display P2Y-like effects in the rat isolated mesenteric arterial bed (Ralevic and Burnstock, 1996) , to our knowledge this is the first report that NADP(H) may act as a direct agonist at P2X receptors. P2X receptors are members of This article has not been copyedited and formatted. The final version may differ from this version. (Kunapuli and Daniel, 1998; North, 2002) . The P2X receptor profile of endothelial cells is less well characterised; however the predominant receptor subtypes on this cell type probably include P2X1 (Harrington and Mitchell, 2004) , P2X4 (Glass et al., 2002) , P2X5 (Schwiebert et al., 2002) and P2X7 (Ramirez and Kunze, 2002) receptors. Moreover, there is some evidence for regional variation (e.g. artery versus vein) in endothelial P2X receptor expression throughout the vasculature (Ray et al., 2002) . Our finding that NF023, at a concentration which selectively targets P2X1 receptors (North, 2002) , caused a ~3-fold rightward shift of the contraction response in endothelium-denuded rings certainly supports the idea that P2X1 are involved in the direct smooth muscle effects of NADPH. Responses to NADPH in rings with an intact endothelium were also partially impaired by NF023; however, given that we were unable to examine the endothelium-dependent component of the response in isolation from the direct smooth muscle effect of NADPH, it is not possible to conclude whether NF023 also has an effect at the endothelial level. Nevertheless we did find that PPADS and α,β-methylene-ATP virtually abolished both the endothelium-dependent and -independent components of the response to NADPH. α,β-methylene-ATP is selective for P2X1 and P2X3 receptor subtypes (North, 2002) .
Given that there is little evidence for P2X3 receptors on endothelial cells these findings with α,β-methylene-ATP probably indicate that the endothelial receptor involved is also of the P2X1 subtype.
While it is not surprising that activation of VSMC P2X receptors would lead to contractions via an increase in VSMC Ca 2+ , it is somewhat surprising that stimulation of This article has not been copyedited and formatted. The final version may differ from this version. (Shirahase et al., 1991) . However, the release of a vasoconstrictor prostanoid does not explain the endothelium-dependent vasocontraction effects to NADPH observed here as the cyclooxygenase inhibitor, indomethacin, had no effect (see Online Data Supplement - Figure 3) . Hence, the mechanism by which P2X receptor stimulation leads to endothelium-dependent contraction remains to be elucidated.
In conclusion, here we have highlighted a novel mechanism(s) of endothelium-dependent and -independent vasocontraction to NADPH involving P2X receptors. As such, this study is the first to identify NADPH as a P2X receptor agonist. In addition, these findings should serve as a warning for future investigations that the effects of extracellular NADPH on vascular tone may not be solely attributable to NADPH oxidase activation.
This article has not been copyedited and formatted. The final version may differ from this version. contractile responses to cumulatively increasing half-log molar concentrations of NADPH in both endothelium-intact and -denuded (E -) rings of aorta following precontraction with U46619, and (B) superoxide production in response to NADPH (100µM) in endothelium-intact tissues.
